Fintel reports that on March 14, 2025, Wedbush downgraded their outlook for Sutro Biopharma (NasdaqGM:STRO) from Outperform ...
Fintel reports that on March 14, 2025, Citizens Capital Markets downgraded their outlook for Sutro Biopharma (NasdaqGM:STRO) ...
Intel's new CEO, Lip-Bu Tan, indicates he wants the company to remain in the expensive foundry business, rather than spin it ...